Quantum BioPharma Ltd. Commences Trading on Upstream

Quantum BioPharma Ltd., a biopharmaceutical firm focused on neurodegenerative and metabolic disorders, has commenced trading on Upstream, a global securities trading app. As of January 14, 2025, shares of Quantum (NASDAQ:QNTM) are available to international investors under the same ticker symbol 'QNTM'. This dual listing aims to broaden investor access beyond traditional markets like Nasdaq, CSE, and Frankfurt.

Upstream, part of the MERJ Exchange market, facilitates trading for investors outside the U.S. through a user-friendly app interface. The process involves a straightforward KYC identity verification, allowing non-U.S. shareholders to deposit or trade shares via credit, debit, or digital currencies. However, U.S. investors are restricted from participating in Upstream's platform.

Zeeshan Saeed, CEO of Quantum, expressed enthusiasm for the listing, emphasizing the value and liquidity added for shareholders. Details on trading and deposit can be accessed through Quantum's official website. The Upstream market operates seven days a week, offering real-time trading and a transparent, manipulation-proof orderbook.